University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 8 of 21
ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance
NCT04895085
Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer
NCT04822597
Peers LEAD Plus Healthy Living With Diabetes (HLWD)
NCT04857411
Effects of Oral Cancer Treatments on Upper Esophageal Opening During Swallowing
NCT04658342
Placental Lesions in Fetal Growth Restrictions
NCT04839185
Teaching Obesity Treatment Options to Adult Learners Intervention Via VA Video Connect
NCT04878289
Stroke Prevention in the Wisconsin Native American Population
NCT04382963
Human Cerebral Blood Flow Regulation
NCT04265053
Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease
NCT04818892
Benefits of Coding Training on Young Adults With Developmental Disabilities
NCT05132491
Parent-Level Predictors of Early Language Interaction Quality and Intervention Outcomes
NCT03525951
Sensory Training for Visual Motion Sickness
NCT04420949
Massed and Spaced HMP App Dosage Study
NCT04741529
Community Acquired Pneumonia in Older Adults
NCT04709978
Financial Incentives for Smoking Cessation Treatment Engagement
NCT04601870
Low-Carb/Time-restricted Feeding Protocol in Insulin-Using Type 2 Diabetics
NCT04558827
BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19)
NCT05087524
Optimizing Recovery in Abdominoplasty
NCT04254692
Patient Reported Outcomes Following Targeted Muscle Reinnervation
NCT04658368
Cessation Screening Project
NCT04188873
Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder
NCT04059549
Preoperative Steroids in Autoimmune Thyroid Disease
NCT04542278
Rehabilitation Manometry Study
NCT04130867
Physical Activity Promotion for Breast and Endometrial Cancer Survivors
NCT04262180
A Communication Tool to Assist Older Adults Facing Dialysis Choices
NCT04466865
PROMMO Trial: Oral Misoprostol vs IV Oxytocin
NCT04478942
Prophylactic Muscle Flaps in Vascular Surgery
NCT04399044
Blue Light Therapy of C. Acnes
NCT04300010
Reducing Surgical Readmissions Through Mobile Technology
NCT04540315
Repeat Testing for SARS-CoV-2
NCT04579549
Interventions for Patients With Alzheimer's Disease and Dysphagia
NCT03682081
Pathways for Parents After Incarceration Feasibility Study
NCT04525703
HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders
NCT04456504
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
NCT04084210
Fostering MAT Use in Justice Populations
NCT04363320
Rapid, Onsite COVID-19 Detection
NCT04460690
SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding
NCT04478019
COVID-19 and the Healthy Minds Program for Educators
NCT04426318
COVID EHR COHORT at the University of Wisconsin
NCT04506528
Examining the Effectiveness of Cognitive Training
NCT04344028
Mobile Health for Alcohol Use Disorders in Clinical Practice
NCT04011644
Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3
NCT04268173
Health Systems Reach Interventions Project
NCT04199117
Exercise in Adolescents With Insulin Resistance
NCT04154865
The Effect of Ketogenic Dietary Therapy on Sleep in Adult Epilepsy
NCT04193891
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells
NCT03798301
Promoting Clinical Guidelines for Opioid Prescribing
NCT04044521
Community Paramedic Coaching Program for Caregivers and People With Dementia
NCT04239924
Stress-physiology Coherence, Interoception, and Well-being Following Mindfulness Training or Tracking Time Spent on Mobile Device
NCT04125758
Abaloparatide Before Total Knee Arthroplasty
NCT04167163
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.